Canadian efforts to prevent and control hypertension

Canadian Journal of Cardiology

Volumn 26, Issue SUPPL. C, 2010, Pages 14C-17C

  Campbell, Norman R C ^a   Chen, Guanmin ^a  

^a LIBIN CARDIOVASCULAR INSTITUTE OF ALBERTA   (Canada)

Author keywords

Education; Epidemiology; High blood pressure; Hypertension; Knowledge translation

Indexed keywords

SODIUM;

AWARENESS; BLOOD PRESSURE REGULATION; CANADA; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; DISEASE CONTROL; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HUMAN; HYPERTENSION; KNOWLEDGE; MORTALITY; ORGANIZATION; PREVALENCE; PUBLIC HEALTH; SCIENTIST; SODIUM INTAKE; STRATEGIC PLANNING; UNITED STATES; ARTICLE; DIET THERAPY; DIETETICS; HEALTH CARE POLICY; HEART DISEASE; INCIDENCE; RISK FACTOR;

CANADA; DIETETICS; HEALTH EDUCATION; HEALTH POLICY; HEART DISEASES; HUMANS; HYPERTENSION; INCIDENCE; NUTRITION THERAPY; PREVALENCE; RISK FACTORS;

EID: 77957661157     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(10)71076-X     Document Type: Conference Paper

References (26)

1. Lawes CM, Vander HS, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet 2008;371:1513-8.
2. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: A systematic review. J Hypertens 2004;22:11-9.
3. Bild D, Teutsch SM. The control of hypertension in persons with diabetes: A public health approach. Public Health Rep 1987;102:522-9.
4. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KKL. The progression from hypertension to congestive heart failure. JAMA 1996;275:1557-62.
5. Kannel WB, Wolf PA, Verter J, McNamara PM. Epidemiologic assessment of the role of blood pressure in stroke. The Framingham Study. JAMA 1970;214:301-10.
6. Haider AW, Chen L, Larson MG, Evans JC, Chen MH, Levy D. Antecedent hypertension confers increased risk for adverse outcomes after initial myocardial infarction. Hypertension 1997;30:1020-4.
7. Gaziano TA, Bitton A, Anand S, Weinstein MC. The global cost of nonoptimal blood pressure. J Hypertens 2009;27:1472-77.
8. Joffres MR, Hamet P, MacLean DR, L'Italien GJ, Fodor G. Distribution of blood pressure and hypertension in Canada and the United States. Am J Hypertens 2001;14:1099-105.
9. Chockalingam A, Campbell N, Ruddy T, Taylor G, Stewart P. Canadian National High Blood Pressure Prevention and Control Strategy. Can J Cardiol 2000;16:1087-93.
10. Zarnke KB, Campbell NRC, McAlister FA, Levine M. A novel process for updating recommendations for managing hypertension: Rationale and methods. Can J Cardiol 2000;16:1094-102.
11. Campbell NR, Onysko J. The Outcomes Research Task Force and the Canadian Hypertension Education Program. Can J Cardiol 2006;22:556-8.
12. Campbell NRC. Canada Chair in hypertension prevention and control: A pilot project. Can J Cardiol 2007;23:557-60.
13. Campbell NR, Petrella R, Kaczorowski J. Public education on hypertension: A new initiative to improve the prevention, treatment and control of hypertension in Canada. Can J Cardiol 2006;22:599-603.
14. Califf RM. A virtuous cycle to improve hypertension outcomes at a national level: Linking public health and individualized medicine. Hypertension 2009;53:105-7.
15. Petrella RJ, Speechley M, Kleinstiver PW, Ruddy T. Impact of a social marketing media campaign on public awareness of hypertension. Am J Hypertens 2005;18:270-5.
16. Campbel NRC. Hypertension prevention and control in Canada. J Am Soc Hypertens 2008;2:97-105.
17. Khan NA, Hemmelgarn B, Herman RJ, et al. The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2 - therapy. Can J Cardiol 2009;25:287-98.
18. McAlister FA. The Canadian Hypertension Education Program - A unique Canadian initiative. Can J Cardiol 2006;22:559-64.
19. Onysko J, Maxwell C, Eliasziw M, Zhang J, Johansen H, Campbell N. Large increases in hypertension diagnosis and treatment in Canada following a health care professional education program. Hypertension 2006;48:853-60.
20. Hemmelgarn BR, Chen G, Walker R, et al. Trends in antihypertensive drug prescriptions and physician visits in Canada between 1996 and 2006. Can J Cardiol 2008;24:507-12.
21. Campbell NR, Brant R, Johansen H, et al. Increases in antihypertensive prescriptions and reductions in cardiovascular events in Canada. Hypertension 2009;53:128-34.
22. McAlister FA, Feldman RD, Wyard K, Brant R, Campbell NR. The impact of the CHEP in its first decade. Eur Heart J 2009;30:1434-9.
23. Leenen FH, Dumais J, McInnis NH, et al. Results of the Ontario survey on the prevalence and control of hypertension. CMAJ 2008;178:1441-49.
24. Campbell NR, So L, Amankwah E, Quan H, Maxwell C. Characteristics of hypertensive Canadians not receiving drug therapy. Can J Cardiol 2008;24:485-90.
25. Penz ED, Joffres MR, Campbell NR. Reducing dietary sodium and decreases in cardiovascular disease in Canada. Can J Cardiol 2008;24:497-501.
26. Joffres M, Campbell NRC, Manns B, Tu K. Estimate of the benefits of a population-based reduction in dietary sodium additives on hypertension and its related health care in Canada. Can J Cardiol 2007; 23:437-43.